Skip to content
  • Saturday, 15 August 2026
  • 12:27 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Neuroscience & Brain Research

King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286

Rifan Muazin Jul 25, 2026 0

Researchers at King’s College London have identified a promising new therapeutic strategy for Alzheimer’s disease by targeting several of the…

Read More
Neuroscience & Brain Research

King’s College London Researchers Identify KCL-286 as a Multitarget Breakthrough for Early-Stage Alzheimer’s Treatment

Rifan Muazin Jul 17, 2026 0

The landscape of neurodegenerative research has shifted significantly following a landmark discovery by scientists at King’s College London (KCL), who…

Read More
Advanced Materials Science

King’s College London Scientists Unveil Novel Aluminum Molecule as Sustainable Alternative to Precious Metal Catalysts

Nila Kartika Wati May 16, 2026 0

A research team at King’s College London has announced the discovery of a pioneering molecular form of aluminum that could…

Read More
Advanced Materials Science

King’s College London Researchers Discover Novel Aluminum Structure Capable of Replacing Precious Metals in Industrial Catalysis

Nila Kartika Wati May 9, 2026 0

A team of scientists at King’s College London has identified a new form of aluminum, one of the most abundant…

Read More
Advanced Materials Science

King’s College London Researchers Identify a New Form of Aluminum as a Sustainable and Cost-Effective Alternative to Rare Earth Metals

Nila Kartika Wati May 1, 2026 0

In a landmark development for the field of inorganic chemistry, a team of scientists at King’s College London has announced…

Read More
Breakthrough Combination Therapy Offers New Hope for Acute Myelogenous Leukemia Treatment Through Epigenetic ReprogrammingBuilding Local AI Systems: Qwen3.6 + MCPsInvasive goldfish trigger a regime shift in experimental lake ecosystems of varying trophic stateInsilico CEO Sees Potentially $2.75 Billion Collaboration as ‘Fusing Lilly’s Clinical Excellence’ with Insilico’s ‘End-to-End AI Engine’
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactLLMOps in 2026: The 10 Tools Every Team Must HaveThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ